pharmacotherapy

(redirected from pharmacotherapies)
Also found in: Medical, Encyclopedia.

phar·ma·co·ther·a·py

 (fär′mə-kō-thĕr′ə-pē)
n. pl. phar·ma·co·ther·a·pies
Treatment of disease through the use of drugs.

pharmacotherapy

(ˌfɑːməkəˈθɛrəpɪ)
n
(Pharmacology) the healing and cure of illness by the administration of drugs
References in periodicals archive ?
Concurrent pharmacotherapies could include: emollients, corticosteroids, vitamin D3 analogues, tazarotene, coal tar, dithranol, methotrexate (MTX), cyclosporine, retinoids, fumarates and/or biological agents.
a leader in the worlds of corporate and academic drug research, has been appointed Director of NIDA's Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA).
Whereas all presently marketed pharmacotherapies for the treatment of alcoholism aim at complete abstinence, nalmefene is developed for the reduction of heavy drinking.
Those guidelines, published in 2000, support increased coverage of tobacco-cessation programs, including behavioral therapies and Food and Drug Administration-approved pharmacotherapies.
The most comprehensive text of its kind, this book addresses both the management of opioid withdrawal and opioid maintenance therapy, and combines up-to-date reviews of the scientific literature with evidence-based clinical guidelines for all of the relevant pharmacotherapies.
Patients with a certain gene variant drank less and experienced better overall clinical outcomes than patients without the variant while taking the medication naltrexone, according to an analysis of participants in the National Institutes of Health's 2001-2004 COMBINE (Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence) Study.
Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA) at NIDA.
Structured behavioural support programmes aid cessation attempts as do a number of pharmacotherapies, most notably nicotine replacement treatments and bupropion.
This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain.
Pharmaceutical companies need to learn that diagnostics, like the more familiar pharmacotherapies, respond to long-range planning, branded marketing strategies, and direct selling.